Physician profile
Alex Willis
NPI 1316442288
$4,855.16
in general payments reported to CMS, 2019-2025
15 companies · $879 in 2025
The $879 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $395 · 2023: $1,131 · 2024: $2,449 · 2025: $879.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,663 · Travel and Lodging: $797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,663.26 |
| Travel and Lodging | $796.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,728.32 | 2022-2025 | Lensx, Clareon, Wavelight Ex500 Excimer Laser |
| Bausch & Lomb Americas INC. | $313.28 | 2024-2025 | Vyzulta, Miebo |
| Abbvie INC. | $227.49 | 2022-2024 | |
| New World Medical,INC. | $107.71 | 2022-2024 | Clearpath, Streamline, Kahook Dual Blade |
| Novartis Pharmaceuticals Corporation | $75.32 | 2022-2023 | |
| Carl Zeiss Meditec USA, INC. | $61.69 | 2025 | Veracity Surgical, Visumax |
| Glaukos Corporation | $59.18 | 2024 | Idose |
| Sight Sciences, INC. | $58.20 | 2024 | Omni Surgical System |
| Sun Pharmaceutical Industries INC. | $57.75 | 2023-2025 | Cequa |
| Oyster Point Pharma, INC. | $50.19 | 2023-2024 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $48.15 | 2025 | Xdemvy |
| Alimera Sciences, INC. | $26.79 | 2022 | |
| Astellas Pharma US INC | $21.88 | 2023 | |
| Rayner Intraocular Lenses Limited | $19.21 | 2024 | Omidria |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Willis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.